Campbell & Co Investment Adviser’s Guardant Health GH Stock Holding History

Campbell & Co Investment Adviser’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.48M	Buy	48,547 +35,790	+281%	+$3.59M	0.26%	88
2025 Q4	$1.3M	Sell	12,757 -6,271	-33%	-$561K	0.06%	459
2025 Q3	$1.19M	Buy	+19,028	New	+$1.04M	0.09%	348
2025 Q1	–	Sell	-56,389	Closed	-$1.72M	–	1138
2024 Q4	$1.72M	Buy	+56,389	New	+$1.59M	0.13%	221
2023 Q4	–	Sell	-32,396	Closed	-$960K	–	1181
2023 Q3	$960K	Buy	+32,396	New	+$1.14M	0.11%	281

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Campbell & Co Investment Adviser's GH Position: Q1 2026 in Review

Campbell & Co Investment Adviser increased its Guardant Health (GH) stake by 281% in Q1 2026, buying an estimated $3.59M and bringing the position to 48,547 shares worth $4.48M. The position accounts for 0.26% of the portfolio, ranked #88.

Campbell & Co Investment Adviser first reported a position in GH in Q3 2023 and has held it in 5 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Campbell & Co Investment Adviser held 48,547 shares of Guardant Health worth $4.48M as of Q1 2026.
Campbell & Co Investment Adviser bought 35,790 Guardant Health shares in Q1 2026, an estimated $3.59M.
Guardant Health made up 0.26% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #88 holding.
Campbell & Co Investment Adviser first reported a position in Guardant Health in Q3 2023 and has held it in 5 quarters since.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.